A recent retrospective study has shed new light on the effectiveness of chimeric antigen receptor T cell therapy for patients ...

Navi Mumbai: In a medical breakthrough at Kokilaben Dhirubhai Ambani Hospital, Navi Mumbai, a 39-year-old Rijesh Nair, a ...

A 19-year-old has shared the pre-cancer symptoms he noticed prior to being diagnosed with with stage four Hodgkin lymphoma.

Follicular lymphoma is considered an indolent disease, with long-term tumour control achieved by first-line ...

Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma.

T-cell therapy yielded encouraging response rates and safety findings among patients with relapsed or refractory chronic ...

Tafasitamab increased progression free survival by about 9 months when compared to placebo, according to recent study data.

Axicabtagene ciloleucel had durable responses, long-term survival, and consistent outcomes in patients with relapsed or ...

Georgie Swallow was just 28-years-old when she received the devastating news that she had stage 4 Hodgkin lymphoma ...

Georgie Swallow was diagnosed with stage 4 Hodgkin lymphoma in June 2017 after she ignored her symptoms for months believing ...

Non-transplant salvage therapy for low-risk relapsed/refractory pediatric classical Hodgkin lymphoma (cHL) had high rates of ...

Caribou Biosciences, Inc. data from phase 1 ANTLER study is expected in 1H 2025. Click here to find out why I'm neutral on ...